| Abaloparatide: a review of preclinical and clinical studies MB Brent European Journal of Pharmacology 909, 174409, 2021 | 36 | 2021 |
| A Systematic Review of Animal Models of Disuse-Induced Bone Loss MB Brent, A Brüel, JS Thomsen Calcified Tissue International, 1-15, 2020 | 36 | 2020 |
| PTH (1–34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats MB Brent, A Brüel, JS Thomsen Bone 110, 244-253, 2018 | 36 | 2018 |
| Teriparatide and abaloparatide have a similar effect on bone in mice MB Brent, FE Stoltenborg, A Brüel, JS Thomsen Frontiers in Endocrinology 12, 628994, 2021 | 19 | 2021 |
| Disuse osteopenia induced by botulinum toxin is similar in skeletally mature young and aged female C57BL/6J mice JB Vegger, A Brüel, MB Brent, JS Thomsen Journal of bone and mineral metabolism 36, 170-179, 2018 | 18 | 2018 |
| A review of the skeletal effects of exposure to high altitude and potential mechanisms for hypobaric hypoxia-induced bone loss MB Brent Bone 154, 116258, 2022 | 17 | 2022 |
| Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice MB Brent, JS Thomsen, A Brüel Scientific Reports 11 (1), 12258, 2021 | 14 | 2021 |
| Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies MB Brent Pharmacology & Therapeutics, 108383, 2023 | 12 | 2023 |
| The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice MB Brent, JS Thomsen, A Brüel Bone Reports 8, 9-17, 2018 | 12 | 2018 |
| The efficacy of PTH and abaloparatide to counteract immobilization-induced osteopenia is in general similar MB Brent, JS Thomsen, A Brüel Frontiers in Endocrinology 11, 588773, 2020 | 11 | 2020 |
| Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A MB Brent, A Lodberg, JS Thomsen, A Brüel MethodsX 7, 101079, 2020 | 11 | 2020 |
| Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats MB Brent, A Brüel, JS Thomsen Bone 160, 116417, 2022 | 10 | 2022 |
| Hypobaric hypoxia deteriorates bone mass and strength in mice MB Brent, T Emmanuel, U Simonsen, A Brüel, JS Thomsen Bone 154, 116203, 2022 | 10 | 2022 |
| Artificial intelligence-assisted identification and quantification of osteoclasts T Emmanuel, A Brüel, JS Thomsen, T Steiniche, MB Brent MethodsX 8, 101272, 2021 | 9 | 2021 |
| Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice MB Brent, A Lodberg, FD Bromer, BCJ van der Eerden, M Eijken, A Brüel, ... Bone 142, 115692, 2021 | 8 | 2021 |
| Animal models of disuse-induced bone loss: study protocol for a systematic review MB Brent, A Brüel, JS Thomsen Systematic Reviews 9, 1-6, 2020 | 7 | 2020 |
| Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice TG Sørensen, MB Brent, JS Thomsen, A Brüel Bone 131, 115183, 2020 | 7 | 2020 |
| The effect of normobaric intermittent hypoxia therapy on bone in normal and disuse osteopenic mice FD Bromer, MB Brent, M Pedersen, JS Thomsen, A Brüel, CB Foldager High Altitude Medicine & Biology 22 (2), 225-234, 2021 | 6 | 2021 |
| Effect of acetazolamide and zoledronate on simulated high altitude-induced bone loss MB Brent, U Simonsen, JS Thomsen, A Brüel Frontiers in Endocrinology 13, 831369, 2022 | 5 | 2022 |
| Sparse dose-dependent difference in skeletal effects of short-term glucocorticoid excess in outbred Swiss mice MB Brent, A Brüel, JS Thomsen Endocrine and Metabolic Science, 100114, 2021 | 3 | 2021 |
